Is ZMP the toxic metabolite in Lesch-Nyhan disease?

Medical Hypotheses
José M López

Abstract

The genetic deficiency of hypoxanthine-guanine phosphoribosyltransferase (HPRT), located on the X chromosome, causes a severe neurological disorder in man, known as Lesch-Nyhan disease (LND). The enzyme HPRT is part of the savage pathway of purine biosynthesis and catalyzes the conversion of hypoxanthine and guanine to their respective nucleotides, IMP and GMP. HPRT deficiency is associated with a relatively selective dysfunction of brain dopamine systems. Several metabolites that accumulate in the patients (phosphoribosylpyrophosphate (PRPP), hypoxanthine, guanine, xanthine, and Z-nucleotides) have been proposed as toxic agents in LND. Some authors have pointed that Z-riboside, derived from the accumulation of ZMP, could be the toxic metabolite in LND. However, the available experimental data support a better hypothesis. I suggest that ZMP (and not Z-riboside) is the key toxic metabolite in LND. ZMP is an inhibitor of the bifunctional enzyme adenylosuccinate lyase, and a deficiency of this enzyme causes psychomotor and mental retardation in humans. Moreover, it has been reported that ZMP inhibits mitochondrial oxidative phosphorylation and induces apoptosis in certain cell types. ZMP is also an activator of the AMP-activated p...Continue Reading

References

Jun 1, 1985·Neurology·F S SilversteinN L Edwards
Jan 1, 1986·Annual Review of Physiology·G Rudnick
Jan 1, 1985·Neuroscience and Biobehavioral Reviews·A A Baumeister, G D Frye
Dec 1, 1985·The Journal of Clinical Investigation·Y Sidi, B S Mitchell
Nov 5, 1981·The New England Journal of Medicine·K G LloydI H Fox
Jun 1, 1993·Journal of Neurochemistry·H A JinnahT Friedmann
Jun 13, 1996·The New England Journal of Medicine·M ErnstR M Cohen
May 28, 1996·Proceedings of the National Academy of Sciences of the United States of America·D F WongG R Breese
Apr 13, 2000·Brain Research. Brain Research Reviews·J E VisserH A Jinnah
Jun 15, 2000·Environmental Health Perspectives·W L Nyhan
May 9, 2002·The Biochemical Journal·Lynette D FairbanksH Anne Simmonds
Nov 8, 2002·The Journal of Nutrition·Wantanee KriengsinyosPaul B Pencharz
Jan 4, 2003·The Journal of Clinical Investigation·Benoit ViolletSophie Vaulont
Jan 28, 2003·Biochemical Society Transactions·B E KempL A Witters
Jun 15, 2004·Medical Hypotheses·Vladimir Kostadinov Neychev, Vanyo Ivano Mitev
Oct 6, 2005·The Journal of Biological Chemistry·Yossi DagonElliot M Berry
Mar 22, 2006·Brain : a Journal of Neurology·H A JinnahUNKNOWN Lesch-Nyhan Disease International Study Group
Mar 22, 2007·Neurobiology of Disease·Kiyoshi EgamiH A Jinnah
May 8, 2007·Journal of Neuropathology and Experimental Neurology·Marc R Del Bigio, William C Halliday
Aug 23, 2007·Nature Reviews. Molecular Cell Biology·D Grahame Hardie
Dec 7, 2007·The Journal of Biological Chemistry·Rintaro OkoshiHarutoshi Kizaki
Mar 4, 2008·Neuroscience·J C LewersH A Jinnah
Apr 12, 2008·Purinergic Signalling·Piero Luigi Ipata, Maria Grazia Tozzi
Apr 29, 2008·Molecular Cell·Dana M GwinnReuben J Shaw

❮ Previous
Next ❯

Citations

Sep 10, 2011·The Journal of Endocrinology·J JeyabalanC Chenu
Jan 24, 2015·Orphanet Journal of Rare Diseases·Irène Ceballos-PicotBenoît Pinson
May 26, 2016·Life Sciences·Sarah K TschirnerVolkhard Kaever
May 19, 2018·The FEBS Journal·Marcella CamiciMaria Grazia Tozzi
Apr 11, 2018·Nucleosides, Nucleotides & Nucleic Acids·Rosa J Torres, Juan G Puig
Nov 18, 2018·International Journal of Molecular Sciences·Mercedes Garcia-GilMaria Grazia Tozzi
May 21, 2020·Proceedings of the National Academy of Sciences of the United States of America·José M LópezH A Jinnah
Dec 12, 2018·PloS One·Lucie MádrováMarie Zikánová
Jan 20, 2019·Cells·Bertrand Daignan-Fornier, Benoît Pinson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis